-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pamidronate disodium is a synthetic analogue of natural vitamin D steroid hormones.
It is primarily used in the treatment of osteoporosis, as well as to prevent and treat certain types of bone loss.
The production process of pamidronate disodium involves a series of chemical reactions that convert starting materials into the final product.
- Chemical Synthesis:
The production of pamidronate disodium begins with the synthesis of several key intermediates.
These intermediates are then converted into the final product through a series of chemical reactions. - Purification:
After the synthesis of the intermediates, they are purified to remove any impurities and ensure the quality of the final product.
This step is critical, as impurities can interfere with the effectiveness of the drug. - Crystallization:
The purified intermediates are then crystallized to produce large, pure crystals of the compound.
This step is important, as it allows for the easy isolation and purification of the final product. - Hydrolysis:
In the final step of the production process, the crystalline compound is treated with a hydrochloric acid solution to remove any remaining impurities and convert it into the final form of pamidronate disodium.
Overall, the production of pamidronate disodium involves a series of chemical reactions and purification steps that convert starting materials into the final product.
The process requires specialized equipment and a high degree of technical expertise, and is typically carried out in a controlled environment, such as a pharmaceutical manufacturing facility.
The end product is a high-purity form of pamidronate disodium that is used to treat osteoporosis and other bone-related conditions.